J.A. Sauceda, K. Dubé, B. Brown, A.E. Pérez, C.E. Rivas, D. Evans, C.B. Fisher. Framing a Consent Form to Improve Knowledge and Determine How This Affects Willingness to Participate in HIV Cure-Research Research: An Experimental Survey Study. Journal of Empirical Research on Human Research Ethics 2020; Dec 14; 1556264620981205. PubMed: https://pubmed.ncbi.nlm.nih.gov/33307932/
Literature Focused on the Psychosocial Aspects of HIV Cure Research Participation
Dubé, K., Ndukwe, S. O., Korolkova, A., Dee, L., Sugarman, J., & Sauceda, J. A. (2024). Participant experiences in a combination HIV cure-related trial with extended analytical treatment interruption in San Francisco, United States. HIV research & clinical practice, 25(1), 2312318. PubMed: https://pubmed.ncbi.nlm.nih.gov/38348830/
Bilger, A., Plenn, E., Barg, F. K., Rendle, K. A., Carter, W. B., Lamour-Harrington, A., Jones, N., Peterson, B., Sauceda, J. A., Tebas, P., Mounzer, K., Metzger, D., Montaner, L. J., & Dubé, K. (2023). Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States. HIV research & clinical practice, 24(1), 2267825. PubMed: https://pubmed.ncbi.nlm.nih.gov/37837376/
K. Dubé, L. Barr, D. Palm, B. Brown, J. Taylor. Putting Participants at the Centre of HIV Cure Research. Lancet HIV 2019; 6(3): e147 – 9. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30772419
K. Dubé, S. Eskaf, L. Barr, D. Palm, E. Hogg, J.M. Simoni, J. Sugarman, B. Brown, J.A. Sauceda, L. Henley, S. Deeks, L. Fox, R.T. Gandhi, D. Smith, J.Z. Li. Participant Perspectives and Experiences Following an Intensively Monitored Antiretroviral Pause (IMAP): Results from the AIDS Clinical Trials Group (ACTG) 5345 Biomarker Study. AIDS Research and Human Retroviruses 2022; 38(6): 510-7. PubMed: https://pubmed.ncbi.nlm.nih.gov/35323030/
K.L. Diepstra, L. Barr, D. Palm, E. Hogg, K.R. Mollan, L. Henley, A.M. Stover, J.M. Simoni, J. Sugarman, B. Brown, J.A. Sauceda, S. Deeks, L. Fox, R.T. Gandhi, D. Smith, J.Z. Li, K. Dubé. Participant Perspectives Entering an Intensively Monitored Antiretroviral Pause: Results from the AIDS Clinical Trial Group A5345 Study. AIDS Research and Human Retroviruses 2021; 37(6): 489 – 501. PubMed: https://pubmed.ncbi.nlm.nih.gov/33472545/
K. Dubé, L. Hosey, K. Starr, L. Barr, D. Evans, E. Hoffman, D.M. Campbell, J. Simoni, J. Sugarman, J. Sauceda, B. Brown, K.L. Diepstra, C. Godfrey, D.R. Kuritzkes, D.A. Wohl, R. Gandhi, E. Scully. Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group (ACTG) 5366. AIDS Research and Human Retroviruses 2020; 36(4): 268 – 82. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32160755
Literature Pertinent to Delphi Consensus Building Challenges
K. Dubé, T. Morton, L. Fox, L. Dee, D. Palm, T. J. Villa, W. Freshwater, J. Taylor, G. Graham, W. B. Carter, J. A. Sauceda, M. J. Peluso, A. Rid. A Partner Protection Package for HIV CURE-Related Trials Involving Analytical Treatment Interruptions. The Lancet Infectious Diseases. (2023). PubMed: https://pubmed.ncbi.nlm.nih.gov/37295453/
K. Dubé, J. Kanazawa, C. Campbell, C. Boone, A.C. Maragh-Bass, D.M. Campbell, M. Agosto-Rosario, J.K. Stockman, T. Poteat, M.O. Johnson, P. Saberi, J.A. Sauceda. Considerations for Involving Women and Racial, Ethnic, Sexual and Gender Minorities in HIV Cure-Related Research with Analytical Treatment Interruption: A Qualitative Inquiry. AIDS Research and Human Retroviruses 2022; 38(1): 50 – 63. PubMed: https://pubmed.ncbi.nlm.nih.gov/33947268/
T. Poteat, A. Aqil, D. Corbett, D. Evans, K. Dubé. “I Would Really Want to Know That They Had My Back”: Transgender Women’s Perceptions of HIV Cure-Related Research in the United States. PLoS One 2020; 15(12): e0244490. PubMed: https://pubmed.ncbi.nlm.nih.gov/33382760/
Literature Pertinent to Partner Protections during ATIs
K. Dubé, J. Kanazawa, L. Dee, J. Taylor, D.M. Campbell, B. Brown, M.O. Johnson, P. Saberi, J.A. Sauceda, J. Sugarman, M.J. Peluso. Ethical and Practice Considerations for Mitigating Risks to Sexual Partners during Analytical Treatment Interruptions in HIV Cure-Related Research. HIV Research and Clinical Practice 2021 Mar 24: 1 – 17. PubMed: https://pubmed.ncbi.nlm.nih.gov/33757411/
M. J. Peluso, L. Dee, D. Campbell, J. Taylor, R. Hoh, R.L. Rutishauser, J. Sauceda, S. G. Deeks, K. Dubé. A Collaboratory, Multi-Disciplinary Approach to Risk Mitigation during HIV Analytical Treatment Interruption. Journal of Virus Eradication 2020; 6(1): 34 – 7. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/32175090
K. Dubé, H. Agarwal, J.K. Stockman, J.D. Auerbach, J.A. Sauceda, A.A. Conroy, M.O. Johnson. “I would absolutely need to know that my partner is still going to be protected”: Perceptions of HIV Cure-Related Research among Diverse HIV Serodifferent Couples in the United States. AIDS Research and Human Retroviruses 2022 Aug. PubMed: https://pubmed.ncbi.nlm.nih.gov/35972752/
D.M. Campbell*, K. Dubé* (joint first authors), P.D. Cowlings, P. Dionicio, R.M. Tam, H. Agarwal, J.K. Stockman, D.J. Auerbach, J.A. Sauceda, A.A. Conroy, M.O. Johnson. “It comes altogether as one”: Perceptions of Analytical Treatment Interruptions and Partner Protections among Racial, Ethnic, Sex and Gender Diverse HIV Serodifferent Couples in the United States. BMC Public Health 2022 Jul 9; 22(1): 1317. PubMed: https://pubmed.ncbi.nlm.nih.gov/35810288/
Other Literature of Interest
K. Dubé, D. Mthimkhulu, W. Ngcobo, D. Mindry, L. Maphalala, V. Pillay, W. Tran, A. Korolkova, T. Ndung'u, K. Dong. 'With this Study, We Have Hope that Something is Coming': Community Members' Perceptions of HIV Cure-related Research in Durban, South Africa - A Qualitative Focus Group Study. (2023). PubMed: https://pubmed.ncbi.nlm.nih.gov/37555592/
K. Dubé, J. D. Auerbach, M. J. Stirratt, P. Gaist. Applying the Functional Behavioral and Social Sciences Research (BSSR) Framework to HIV Cure Research. Journal of the International AIDS Society (JIAS) 2019; 22: e25404. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31665568.
B. Julg, L. Dee, J. Ananworanich, D. Barouch, K. Bar, M. Caskey, D. Colby, L. Dawson, K. Dong, K. Dubé, J. Eron, J. Frater, R. Gandhi, R. Geleziunas, P. Goulder, G. Hanna, R. Jefferys, R. Johnston, D. Kuritzkes, J. Li, U. Likhitwonnawut, J. van Lunzen, J. Martinez-Picado, V. Miller, L. Montaner, D. Nixon, D. Palm, G. Pantaleo, H. Peay, D. Persaud, J. Salzwedel, K. Salzwedel, T. Schacker, V. Sheikh, O. Søgaard, S. Spudich, K. Stephenson, J. Sugarman, J. Taylor, P. Tebas, C. Tiemessen, R. Tressler, C. Weiss, S. Zheng, M. Robb, N. Michael, J. Mellors, S. Deeks, B. Walker. Recommendations for Analytical Treatment Interruption in HIV Remission Trials – Report of a Consensus Workshop. Lancet HIV 2019; 6(4): e259 – 68. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30885693
K. Dubé, S. Eskaf, D. Evans, J. Sauceda, P. Saberi, B. Brown, D. Averitt, K. Martel, M. Meija, D. Campbell, L. Barr, J. Kanazawa, K. Perry, H. Patel, S. Luter, T. Poteat, J.D. Auerbach, D.A. Wohl. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Research and Human Retroviruses 2020; 36(4): 324 – 48. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31608651
